Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Jeffrey H. Lin"'
Autor:
Il-Kyu Kim, Mark S. Diamond, Salina Yuan, Samantha B. Kemp, Benjamin M. Kahn, Qinglan Li, Jeffrey H. Lin, Jinyang Li, Robert J. Norgard, Stacy K. Thomas, Maria Merolle, Takeshi Katsuda, John W. Tobias, Timour Baslan, Katerina Politi, Robert H. Vonderheide, Ben Z. Stanger
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Acquired resistance to immunotherapy remains a critical yet incompletely understood biological mechanism. Here, using a mouse model of pancreatic ductal adenocarcinoma (PDAC) to study tumor relapse following immunotherapy-induced responses,
Externí odkaz:
https://doaj.org/article/96e408eb89f447649478a14b903b0f6a
Publikováno v:
Cancer Treatment and Research Communications, Vol 40, Iss , Pp 100833- (2024)
Background: The data on immune checkpoint inhibitors (ICI) use in lung cancer individuals generally underrepresented in clinical trials are limited. We aimed to examine the ICI access, safety, and outcome in these populations using real-world data. M
Externí odkaz:
https://doaj.org/article/0ac80a89967d44749331bf0a892c109f
Autor:
Sushila A. Toulmin, Chaitali Bhadiadra, Andrew J. Paris, Jeffrey H. Lin, Jeremy Katzen, Maria C. Basil, Edward E. Morrisey, G. Scott Worthen, Laurence C. Eisenlohr
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Type II alveolar cells play central roles in multiple aspects of lung biology. Here the authors show that type II alveolar cells also constitutively express MHCII, exhibit limited MHCII antigen presentation capacity, and are a component of the host r
Externí odkaz:
https://doaj.org/article/e19c792b6eed4c79a384d45bab80f5de
Publikováno v:
Current Oncology Reports. 25:549-558
Supplementary Figure 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13bd61703be6f8f63fd62e3622aa9a9e
https://doi.org/10.1158/2326-6066.22544406
https://doi.org/10.1158/2326-6066.22544406
Supplementary Figure 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2578badb8caf9a0908b7d71572ee11ec
https://doi.org/10.1158/2326-6066.22544403
https://doi.org/10.1158/2326-6066.22544403
Supplementary Figure 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::285529fe9582d2c8caecab5dca2472b5
https://doi.org/10.1158/2326-6066.22544388.v1
https://doi.org/10.1158/2326-6066.22544388.v1
T-cell recognition of tumor neoantigens is critical for cancer immune surveillance and the efficacy of immunotherapy. Tumors can evade host immunity by altering their antigenicity or orchestrating an immunosuppressive microenvironment, leading to out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1b2b2cfb1c8552148c458eeb6ebc55
https://doi.org/10.1158/2326-6066.c.6550629.v1
https://doi.org/10.1158/2326-6066.c.6550629.v1
Supplementary Figure 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633d51ff36e4b4ac951d0fd6f60c8bfb
https://doi.org/10.1158/2326-6066.22544397
https://doi.org/10.1158/2326-6066.22544397
Supplementary Figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c78154233cca2064237e80bc2e3a94f7
https://doi.org/10.1158/2326-6066.22544415.v1
https://doi.org/10.1158/2326-6066.22544415.v1